Urispas

Urispas is a prescription medication specifically formulated to alleviate the symptoms associated with urinary tract conditions, such as overactive bladder and interstitial cystitis. It functions as an antispasmodic agent, directly targeting the smooth muscle of the urinary tract to reduce spasms, pain, and urgency. By effectively relaxing the bladder muscle, it helps restore comfort and control, significantly improving the quality of life for individuals suffering from these disruptive and often painful conditions. This medication is intended for use under the guidance of a healthcare professional as part of a comprehensive treatment plan.

Features

• Contains the active pharmaceutical ingredient flavoxate hydrochloride.
• Available in convenient 200 mg oral tablet formulation.
• Functions as a direct antispasmodic on the smooth muscle of the urinary tract.
• Designed for systemic absorption and targeted action.
• Prescription-only status ensures supervised, appropriate use.

Benefits

• Provides rapid relief from urinary urgency, frequency, and incontinence.
• Significantly reduces bladder pain and discomfort associated with spasms.
• Helps restore normal urinary function and improves daily comfort.
• Enhances quality of life by minimizing sleep disruptions due to nocturia.
• Supports a comprehensive management plan for chronic urinary conditions.
• Allows for greater social and physical activity without constant concern.

Common use

Urispas is commonly prescribed for the symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency, and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis, or urethrotrigonitis. It is also utilized in cases of overactive bladder and interstitial cystitis/painful bladder syndrome where smooth muscle spasm is a contributing factor to patient discomfort. It is important to note that Urispas treats the symptoms of these conditions but does not cure the underlying cause, such as a bacterial infection, which may require concomitant antibiotic therapy.

Dosage and direction

The typical adult dosage of Urispas is one 200 mg tablet taken three to four times daily. The exact dosage and frequency should be determined by a healthcare provider based on the severity of symptoms and individual patient response. Tablets should be swallowed whole with a full glass of water, with or without food, though taking with food may help minimize potential gastrointestinal upset. It is not recommended for use in children under the age of 12 due to insufficient safety and efficacy data. Treatment duration should be as prescribed; do not adjust the dosage or stop taking the medication without consulting your doctor.

Precautions

Before starting Urispas, inform your healthcare provider of any history of glaucoma, gastrointestinal obstruction, ileus, severe ulcerative colitis, myasthenia gravis, or obstructive uropathy. Use with caution in patients with liver or kidney impairment, as dosage adjustments may be necessary. This drug may cause drowsiness or blurred vision; therefore, patients should exercise caution when driving, operating machinery, or engaging in activities requiring mental alertness until they know how the medication affects them. Elderly patients may be more sensitive to the side effects of this drug, particularly drowsiness, confusion, or constipation.

Contraindications

Urispas is contraindicated in patients with a known hypersensitivity to flavoxate hydrochloride or any of the inactive ingredients in the formulation. It is also contraindicated in individuals with gastrointestinal obstruction, ileus, paralytic ileus, severe ulcerative colitis, toxic megacolon complicating ulcerative colitis, and myasthenia gravis. It should not be used in patients with obstructive uropathy (e.g., bladder neck obstruction due to prostatic hypertrophy) or any condition where inhibition of gastrointestinal motility might be detrimental.

Possible side effect

Common side effects may include nausea, vomiting, dry mouth, nervousness, drowsiness, blurred vision, dizziness, headache, and confusion. These are often mild and transient. Less frequently, patients may experience tachycardia, palpitations, increased ocular tension, urticaria, eosinophilia, leukopenia, fever, and mental confusion in the elderly. Allergic reactions, though rare, can occur. If any side effect becomes severe or persistent, or if you experience signs of an allergic reaction such as rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, or trouble breathing, seek immediate medical attention.

Drug interaction

Urispas may interact with other medications that possess anticholinergic properties (e.g., antihistamines, antispasmodics, antipsychotics, certain antidepressants, anti-Parkinson’s drugs), potentially leading to an additive effect and increased side effects like dry mouth, constipation, drowsiness, and blurred vision. Concurrent use with other CNS depressants (e.g., alcohol, benzodiazepines, opioids) may enhance sedative effects. It may also affect the absorption of other drugs due to its potential impact on gastrointestinal motility. Always provide your doctor and pharmacist with a complete list of all prescription and non-prescription medicines, herbs, and supplements you are taking.

Missed dose

If you miss a dose of Urispas, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up, as this increases the risk of side effects. Maintaining a consistent schedule is important for optimal symptom control. If you are unsure, contact your healthcare provider or pharmacist for advice.

Overdose

In case of suspected overdose, which may manifest as severe anticholinergic effects such as intense drowsiness, dizziness, dry mouth, blurred vision, flushing, fever, breathing difficulties, or seizures, seek emergency medical attention immediately. Contact a poison control center for guidance. Treatment is typically supportive and symptomatic, as there is no specific antidote. Gastric lavage or administration of activated charcoal may be considered if ingestion was recent. Vital signs should be monitored closely.

Storage

Store Urispas tablets at room temperature, between 15°C and 30°C (59°F and 86°F), in a tightly closed container. Keep the medication away from excess light, moisture, and heat. Do not store in the bathroom. Keep all medications out of the reach of children and pets. Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed through a medicine take-back program or by consulting your pharmacist.

Disclaimer

This information is intended for educational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is based on the product’s general characteristics and may not be applicable to every individual.

Reviews

“After struggling with interstitial cystitis for years, Urispas has been a game-changer. The constant urgency and pain have reduced significantly, allowing me to sleep through the night and engage in daily activities without constant interruption. It’s an essential part of my management plan.” – Patient, 48

“My urologist prescribed Urispas for my overactive bladder symptoms. I noticed a difference within a few days. The frequency and sudden urges are much more manageable now. The only side effect I experienced was minor dry mouth, which was a fair trade-off for the relief.” – Patient, 62

“As a physician, I find Urispas to be a valuable tool for managing patients with painful bladder spasms where anticholinergic therapy is indicated. It is generally well-tolerated and provides effective symptomatic relief, improving patients’ quality of life when used appropriately within a treatment regimen.” – Urologist